Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Hengyu Biotechnology

Request full access

CXO platform founded by a scientific research team that provides biosafety testing and related process validation

ChinaFounded 2020Biotech & Life Sciences

About Hengyu Biotechnology

Hengyu Biotech is a leading provider of biological and pharmaceutical testing services, catering to innovative pharmaceutical companies. Operating primarily in the biotechnology and pharmaceutical markets, Hengyu Biotech assists clients throughout the entire drug research and development (R&D) process, from initial R&D stages to market launch. The company’s business model revolves around offering a wide range of testing services, including biosafety testing, viral clearance and inactivation studies, cell bank testing, raw material testing, and quality control of gene and cell therapy products. Hengyu Biotech generates revenue by providing these specialized testing services, which are essential for ensuring the safety and efficacy of new drugs. The company operates BSL-2 laboratories across China and adheres to stringent quality standards, including ISO9001, CNAS, and GLP certifications. Hengyu Biotech is known for its rigorous validation processes, detailed analysis, quick turnaround times, effective system management, and strict data confidentiality, making it a trusted partner in the pharmaceutical industry.

Source: Dealroom company data

At a glance

Status
Operational
Employees
5
Open positions
None listed
Dealroom signal
34.7/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Mar 2024 $28M $110M GP Capital · CMB International · CS Capital · Hongcheng Investment ↗
SERIES A✓Equity / VC Jul 2022 $0 — Haibang Capital · Guofang Capital · Chengshu Investment ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Hengyu Biotechnology website traffic

Latest recorded traffic for Hengyu Biotechnology is 280 monthly website visits, down 74.5% over the last three months. Hengyu Biotechnology's team declined 16.7% over the past year.

Latest monthly visits280 3-month web change-74.5% 1-year team growth-16.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Hengyu Biotechnology in its local ecosystem

Live from Dealroom

The Hengyu Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A9 investors entered at this stage

  • Haibang Capital
  • Guofang Capital
  • Chengshu Investment
  • GP Capital
  • CMB International
  • CS Capital
  • Hongcheng Investment
  • Hangzhou Heda Investment
  • Jiashan Listed Cultivation Fund
Employees 5 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Hengyu Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hengyu Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.